Business Context and Reporting Period
Company: Cloudastructure, Inc. (CSAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2025
Business Overview: Cloudastructure provides cloud-based AI video surveillance and remote guarding security services. The company operates as a single segment focused on the "proptech" space, serving property management companies. It is classified as an Emerging Growth Company and a Smaller Reporting Company.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2025 | Balance Sheet (June 30, 2025) |
|---|---|---|---|
| Revenue | $1,090 | $1,828 | - |
| Gross Profit | $404 | $734 | - |
| Gross Margin | 37.1% | 40.2% | - |
| Net Loss | $(2,011) | $(4,564) | - |
| Loss Per Share (Basic/Diluted) | $(0.14) | $(0.31) | - |
| Cash and Cash Equivalents | - | - | $7,733 |
| Total Assets | - | - | $9,062 |
| Total Liabilities | - | - | $1,002 |
| Working Capital | - | - | $7,862 |
| Accumulated Deficit | - | - | $(45,420) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 267% year-over-year (YoY) for the quarter and 243% YoY for the six-month period. This was driven by a 58-60% increase in customer count and significant growth in hardware sales (863% increase QoQ) and installation services.
- Expense Increases: Operating expenses rose significantly. General and Administrative (G&A) expenses increased 63% (quarter) and 86% (six months), largely due to one-time employee bonuses and higher insurance/legal fees. Sales and Marketing expenses increased 43% (quarter) and 50% (six months) due to new hires and marketing spend.
- Net Loss Expansion: Net loss increased 9% for the quarter and 27% for the six-month period compared to the prior year, despite gross profit increasing by 273% and 701% respectively. The loss expansion is attributed to the aggressive scaling of operating expenses.
- Liquidity Improvement: Cash and cash equivalents surged from $52,000 at year-end 2024 to $7.7 million at June 30, 2025, primarily due to financing activities.
Guidance, Outlook, and Risks
Outlook and Liquidity: Management expects current cash reserves ($7.7 million) combined with available financing lines to fund operations through at least the second quarter of 2026. The company anticipates sustaining operating losses for the foreseeable future as it expands its business and product development.
Financing Activities:
- Series 1 & 2 Preferred: Raised $6.3 million in Series 1 Preferred (closed Jan 2025) and $7.5 million in Series 2 Preferred (closed March/April 2025) from Streeterville Capital, LLC.
- Equity Line: Entered an agreement with Atlas Sciences, LLC to purchase up to $50.0 million of Class A common stock over 24 months.
Risks and Contingencies:
- Going Concern: While liquidity has improved, the company has an accumulated deficit of $45.4 million and relies on future financing to continue operations.
- Customer Concentration: The company has a substantial customer concentration, with a limited number of clients accounting for a significant portion of revenue.
- Regulatory & Security: Risks include evolving privacy regulations regarding biometric data, potential AI liability, and cybersecurity threats.
- Related Party Transactions: Includes leases for aircraft and data center space with entities affiliated with the CEO.
Investor Verification Checklist
- Financing Terms: Verify the specific conversion triggers and dilution risks associated with the Series 1 and Series 2 Preferred stock issued to Streeterville Capital.
- Revenue Quality: Assess the sustainability of the 863% increase in hardware sales and whether this is a one-time installation spike or recurring revenue.
- Expense Run Rate: Confirm if the one-time bonuses paid in Q2 2025 (impacting G&A and R&D) are indicative of future compensation costs or a one-off event.
- Customer Concentration: Review the specific revenue contribution of the top five property management clients mentioned to gauge dependency risk.
- Equity Line Utilization: Monitor the utilization of the $50 million Equity Line with Atlas Sciences and any associated issuance costs.